#cardiovascular

People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.

A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections

A recent Swedish study defined a low-level detectable viral load as between 50 and 999.

The association between viral load and cardiovascular disease risk has been under-investigated among young people with HIV.

This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.

A recent study finds that people with HIV receive insufficient attention to cardiovascular risk.

Lower rates of targeted interventions and care strategies for acute heart problems compared with HIV-negative people are a likely factor.

Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.

The virus, especially if detectable, is tied to disruptions of the resetting of heartbeats.

Having HIV was associated with a lower rate of statin prescriptions among those with an indication for these drugs in a recent study.

That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

Investigators conducted a review of 20 studies covering 55 health outcomes, looking for those associated with HIV.

Users can receive checkup reminders for cholesterol tests and mammograms, among other benefits.

This finding raises concerns that staying off antiretrovirals may raise the risk of more serious cardiovascular problems.

More research on the reasons for this apparent independent link could lead to new prevention approaches.